Baiyunshan Pharma Raises $1.6 Billion in Secondary Offering

Guangzhou Baiyunshan Pharmaceutical Holdings will raise $1.6 billion in a secondary offering, which it will use for various corporate initiatives, including expanding its China's online drug selling effort. One of the investors is Yunfeng, the private equity firm co-founded by Jack Ma, CEO of China's huge Alibaba online marketplace. Mr. Ma's participation attracted a great deal of media attention, even though Yunfeng is buying only one-twentieth of the total offering. Baiyunshan is the first manufacturer of generic Viagra in China. More details.... Stock Symbols: (HK: 874) (NYSE: BABA) Share this with colleagues: // //  
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.